<DOC>
	<DOC>NCT00395941</DOC>
	<brief_summary>Acitretin, when given in combiantion with pioglitazone might achieve better and/or more rapid control of moderate to severe chronic plaque type psoriasis.</brief_summary>
	<brief_title>Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Patients with chronic plaque type psoriasis having body surface area involvement of &gt; 20% Patients of either sex Females who have completed their family and are tubectomized or are postmenopausal i.e. no menstrual bleeding over at least 1 year Age range 1865 years Females of child bearing potential H/O hypersensitivity to acitretin Impaired hepatic function (serum bilirubin, AST, ALT and alkaline phosphatase &gt;1.5 times the upper limit of normal) Impaired renal function (serum creatinine &gt;1.5mg% in males and &gt;1.4 mg% in females) Hyperlipidemia BMI &gt;30 kg /m2 H/O excessive alcohol use Diabetes mellitus Congestive heart failure Ischemic heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>